Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Mar 2026 for TriSalus Life Sciences, Inc., €4,133. Read the official filing
Filing timeline
BuySaleJodi Devlin
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jodi Devlin: trading record in brief
All filings by Jodi Devlin on record concern TriSalus Life Sciences, Inc. Over a trading history stretching from 12 February 2024 to 11 March 2026, the count stands at 6 filings.
Sales make up the whole of the open-market record (1 sale, €4,133). Outside the open market, there are 5 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 20 March 2026 with an open-market sale (€4,133) in TriSalus Life Sciences, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jodi Devlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
1,162 shares@ US$4.133.6% of flowCommon StockSEC:0001628280-26-020190:0
50,000 shares0Common StockSEC:0001992151-25-000004:0
24,131 shares@ US$5.18100.0% of flowCommon StockSEC:0001826667-25-000059:0
5,272 shares0Common StockSEC:0001415889-25-004680:0
10,625 shares0Common StockSEC:0001415889-25-002285:0
17,500 shares0Common StockSEC:0001415889-24-003807:0
6 of 6 declarations
